Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A.

Neurobiol Aging. 2011 Nov;32(11):1942-8. doi: 10.1016/j.neurobiolaging.2009.12.005. Epub 2009 Dec 23.

2.

Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L.

Neurosci Lett. 2006 Mar 20;396(1):23-7. Epub 2006 Jan 6.

PMID:
16406347
3.

Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.

Okonkwo OC, Xu G, Dowling NM, Bendlin BB, Larue A, Hermann BP, Koscik R, Jonaitis E, Rowley HA, Carlsson CM, Asthana S, Sager MA, Johnson SC.

Neurology. 2012 May 29;78(22):1769-76. doi: 10.1212/WNL.0b013e3182583047. Epub 2012 May 16.

4.

Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.

PMID:
25624419
5.

Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.

McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.

Neurosci Lett. 2010 Oct 8;483(1):62-6. doi: 10.1016/j.neulet.2010.07.063. Epub 2010 Aug 1.

PMID:
20678545
6.

Insulin resistance is associated with poorer verbal fluency performance in women.

Ekblad LL, Rinne JO, Puukka PJ, Laine HK, Ahtiluoto SE, Sulkava RO, Viitanen MH, Jula AM.

Diabetologia. 2015 Nov;58(11):2545-53. doi: 10.1007/s00125-015-3715-4. Epub 2015 Aug 15.

PMID:
26276262
7.

Semantic memory activation in amnestic mild cognitive impairment.

Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, Rao SM.

Brain. 2009 Aug;132(Pt 8):2068-78. doi: 10.1093/brain/awp157. Epub 2009 Jun 10.

8.

Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.

Rao SM, Bonner-Jackson A, Nielson KA, Seidenberg M, Smith JC, Woodard JL, Durgerian S.

Neuroimage. 2015 May 1;111:136-46. doi: 10.1016/j.neuroimage.2015.02.011. Epub 2015 Feb 14.

9.

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.

Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.

Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29.

PMID:
18334913
10.

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, Okonkwo OC, La Rue A, Hermann BP, Koscik RL, Jonaitis EM, Sager MA, Asthana S.

JAMA Neurol. 2015 Sep;72(9):1013-20. doi: 10.1001/jamaneurol.2015.0613. Erratum in: JAMA Neurol. 2015 Dec;72(12):1537.

11.

Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.

Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.

Am J Psychiatry. 2006 Sep;163(9):1603-10.

PMID:
16946187
12.

Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.

Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, van der Flier WM.

Neurology. 2008 May 6;70(19 Pt 2):1836-41. doi: 10.1212/01.wnl.0000311446.61861.e3.

PMID:
18458218
13.

APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.

Pievani M, Galluzzi S, Thompson PM, Rasser PE, Bonetti M, Frisoni GB.

Neuroimage. 2011 Apr 1;55(3):909-19. doi: 10.1016/j.neuroimage.2010.12.081. Epub 2011 Jan 9.

PMID:
21224004
14.

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT.

Arch Neurol. 1999 Aug;56(8):961-5.

PMID:
10448801
15.

APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.

Kerchner GA, Berdnik D, Shen JC, Bernstein JD, Fenesy MC, Deutsch GK, Wyss-Coray T, Rutt BK.

Neurology. 2014 Feb 25;82(8):691-7. doi: 10.1212/WNL.0000000000000154. Epub 2014 Jan 22.

16.

Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.

Debette S, Wolf PA, Beiser A, Au R, Himali JJ, Pikula A, Auerbach S, Decarli C, Seshadri S.

Neurology. 2009 Dec 15;73(24):2071-8. doi: 10.1212/WNL.0b013e3181c67833. Epub 2009 Dec 9.

17.

[Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].

Li J, Kuang WH, Li J, Wang X, Huang MS, Wu DP.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Jan;36(1):50-2. Chinese.

PMID:
15702779
18.

Alzheimer disease family history impacts resting state functional connectivity.

Wang L, Roe CM, Snyder AZ, Brier MR, Thomas JB, Xiong C, Benzinger TL, Morris JC, Ances BM.

Ann Neurol. 2012 Oct;72(4):571-7. doi: 10.1002/ana.23643.

19.

Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E.

Neurology. 2001 Oct 23;57(8):1461-6.

PMID:
11673590
20.

Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment.

Bigler ED, Tate DF, Miller MJ, Rice SA, Hessel CD, Earl HD, Tschanz JT, Plassman B, Welsh-Bohmer KA.

J Int Neuropsychol Soc. 2002 Nov;8(7):925-33.

PMID:
12405544

Supplemental Content

Support Center